MedTrace Logo

Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

NCT03697343 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 382

Last updated 2022-12-13

No results posted yet for this study

Summary

Phase III trial comparing local control and side effects after fractionated stereotactic radiotherapy and single session radiosurgery in patients with larger brain metastases (2-4 cm)

Conditions

  • Cerebral Metastases of Solid Cancers

Interventions

RADIATION

Radiosurgery

Radiosurgery with 1 x 18 Gy (2-3 cm) or 1 x 15 Gy (3-4 cm)

RADIATION

Fractionated stereotactic radiotherapy

Fractionated stereotactic radiotherapy with 12 x 4 Gy and 2 mm

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Rainer Fietkau, Prof. · Universitätsklinikum Erlangen, Strahlenklinik

  • Florian Putz, PD Dr.med. · Universitätsklinikum Erlangen, Strahlenklinik

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-18
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03697343 on ClinicalTrials.gov